Your browser does not support JavaScript! Development of a machine learning model for Aspyre Lung (Blood): a new assay for rapid detection of actionable variants from plasma in NSCLC patients | Biofidelity

Development of a machine learning model for Aspyre Lung (Blood): a new assay for rapid detection of actionable variants from plasma in NSCLC patients

November 24, 2024 by Sam

Connect with us

Have questions, need more information, or ready to start your journey? Connect with us below.